147 related articles for article (PubMed ID: 33933552)
1. The dual roles of A20 in cancer.
Shi Y; Wang X; Wang J; Wang X; Zhou H; Zhang L
Cancer Lett; 2021 Jul; 511():26-35. PubMed ID: 33933552
[TBL] [Abstract][Full Text] [Related]
2. TNF-α-induced protein 3 (TNFAIP3)/A20 acts as a master switch in TNF-α blockade-driven IL-17A expression.
Urbano PCM; Aguirre-Gamboa R; Ashikov A; van Heeswijk B; Krippner-Heidenreich A; Tijssen H; Li Y; Azevedo VF; Smits LJT; Hoentjen F; Joosten I; Koenen HJPM
J Allergy Clin Immunol; 2018 Aug; 142(2):517-529. PubMed ID: 29248493
[TBL] [Abstract][Full Text] [Related]
3. A20 inhibits the motility of HCC cells induced by TNF-α.
Wang X; Ma C; Zong Z; Xiao Y; Li N; Guo C; Zhang L; Shi Y
Oncotarget; 2016 Mar; 7(12):14742-54. PubMed ID: 26909601
[TBL] [Abstract][Full Text] [Related]
4. A20 targets PFKL and glycolysis to inhibit the progression of hepatocellular carcinoma.
Feng Y; Zhang Y; Cai Y; Liu R; Lu M; Li T; Fu Y; Guo M; Huang H; Ou Y; Chen Y
Cell Death Dis; 2020 Feb; 11(2):89. PubMed ID: 32015333
[TBL] [Abstract][Full Text] [Related]
5. A20/TNFAIP3 Regulates the DNA Damage Response and Mediates Tumor Cell Resistance to DNA-Damaging Therapy.
Yang C; Zang W; Tang Z; Ji Y; Xu R; Yang Y; Luo A; Hu B; Zhang Z; Liu Z; Zheng X
Cancer Res; 2018 Feb; 78(4):1069-1082. PubMed ID: 29233925
[TBL] [Abstract][Full Text] [Related]
6. Methotrexate limits inflammation through an A20-dependent cross-tolerance mechanism.
Municio C; Dominguez-Soto Á; Fuentelsaz-Romero S; Lamana A; Montes N; Cuevas VD; Campos RG; Pablos JL; González-Álvaro I; Puig-Kröger A
Ann Rheum Dis; 2018 May; 77(5):752-759. PubMed ID: 29431121
[TBL] [Abstract][Full Text] [Related]
7. MiR-125b regulates proliferation and apoptosis of nasopharyngeal carcinoma by targeting A20/NF-κB signaling pathway.
Zheng Z; Qu JQ; Yi HM; Ye X; Huang W; Xiao T; Li JY; Wang YY; Feng J; Zhu JF; Lu SS; Yi H; Xiao ZQ
Cell Death Dis; 2017 Jun; 8(6):e2855. PubMed ID: 28569771
[TBL] [Abstract][Full Text] [Related]
8. Emerging role of zinc finger protein A20 as a suppressor of hepatocellular carcinoma.
Yi PS; Shu Y; Bi WX; Zheng XB; Feng WJ; He LY; Li JS
J Cell Physiol; 2019 Dec; 234(12):21479-21484. PubMed ID: 31134613
[TBL] [Abstract][Full Text] [Related]
9. Roles of A20 in autoimmune diseases.
Zhang M; Peng LL; Wang Y; Wang JS; Liu J; Liu MM; Hu J; Song B; Yang HB
Immunol Res; 2016 Apr; 64(2):337-44. PubMed ID: 26135958
[TBL] [Abstract][Full Text] [Related]
10. Expression, biological activities and mechanisms of action of A20 (TNFAIP3).
Verstrepen L; Verhelst K; van Loo G; Carpentier I; Ley SC; Beyaert R
Biochem Pharmacol; 2010 Dec; 80(12):2009-20. PubMed ID: 20599425
[TBL] [Abstract][Full Text] [Related]
11. Mutation analysis of tumor necrosis factor alpha-induced protein 3 gene in Hodgkin lymphoma.
Etzel BM; Gerth M; Chen Y; Wünsche E; Facklam T; Beck JF; Guntinas-Lichius O; Petersen I
Pathol Res Pract; 2017 Mar; 213(3):256-260. PubMed ID: 28189285
[TBL] [Abstract][Full Text] [Related]
12. Two distinct ubiquitin-binding motifs in A20 mediate its anti-inflammatory and cell-protective activities.
Martens A; Priem D; Hoste E; Vetters J; Rennen S; Catrysse L; Voet S; Deelen L; Sze M; Vikkula H; Slowicka K; Hochepied T; Iliaki K; Wullaert A; Janssens S; Lamkanfi M; Beyaert R; Armaka M; Bertrand MJM; van Loo G
Nat Immunol; 2020 Apr; 21(4):381-387. PubMed ID: 32205881
[TBL] [Abstract][Full Text] [Related]
13. Casp8 acts through A20 to inhibit PD-L1 expression: The mechanism and its implication in immunotherapy.
Zou J; Xia H; Zhang C; Xu H; Tang Q; Zhu G; Li J; Bi F
Cancer Sci; 2021 Jul; 112(7):2664-2678. PubMed ID: 33934451
[TBL] [Abstract][Full Text] [Related]
14. Interplay of Toll-Like Receptor 9, Myeloid Cells, and Deubiquitinase A20 in Periodontal Inflammation.
Crump KE; Oakley JC; Xia-Juan X; Madu TC; Devaki S; Mooney EC; Sahingur SE
Infect Immun; 2017 Jan; 85(1):. PubMed ID: 27849177
[TBL] [Abstract][Full Text] [Related]
15. A20 Ameliorates Intracerebral Hemorrhage-Induced Inflammatory Injury by Regulating TRAF6 Polyubiquitination.
Meng Z; Zhao T; Zhou K; Zhong Q; Wang Y; Xiong X; Wang F; Yang Y; Zhu W; Liu J; Liao M; Wu L; Duan C; Li J; Gong Q; Liu L; Xiong A; Yang M; Wang J; Yang Q
J Immunol; 2017 Jan; 198(2):820-831. PubMed ID: 27986908
[TBL] [Abstract][Full Text] [Related]
16. O-Linked β-N-Acetylglucosamine Modification of A20 Enhances the Inhibition of NF-κB (Nuclear Factor-κB) Activation and Elicits Vascular Protection After Acute Endoluminal Arterial Injury.
Yao D; Xu L; Xu O; Li R; Chen M; Shen H; Zhu H; Zhang F; Yao D; Chen YF; Oparil S; Zhang Z; Gong K
Arterioscler Thromb Vasc Biol; 2018 Jun; 38(6):1309-1320. PubMed ID: 29622561
[TBL] [Abstract][Full Text] [Related]
17. A20 promotes metastasis of aggressive basal-like breast cancers through multi-monoubiquitylation of Snail1.
Lee JH; Jung SM; Yang KM; Bae E; Ahn SG; Park JS; Seo D; Kim M; Ha J; Lee J; Kim JH; Kim JH; Ooshima A; Park J; Shin D; Lee YS; Lee S; van Loo G; Jeong J; Kim SJ; Park SH
Nat Cell Biol; 2017 Oct; 19(10):1260-1273. PubMed ID: 28892081
[TBL] [Abstract][Full Text] [Related]
18. TNFα induces tolerant production of CXC chemokines in colorectal cancer HCT116 cells via A20 inhibition of ERK signaling.
Zhou X; An D; Liu X; Jiang M; Yuan C; Hu J
Int Immunopharmacol; 2018 Jan; 54():296-302. PubMed ID: 29175508
[TBL] [Abstract][Full Text] [Related]
19. Frequent inactivation of A20 in B-cell lymphomas.
Kato M; Sanada M; Kato I; Sato Y; Takita J; Takeuchi K; Niwa A; Chen Y; Nakazaki K; Nomoto J; Asakura Y; Muto S; Tamura A; Iio M; Akatsuka Y; Hayashi Y; Mori H; Igarashi T; Kurokawa M; Chiba S; Mori S; Ishikawa Y; Okamoto K; Tobinai K; Nakagama H; Nakahata T; Yoshino T; Kobayashi Y; Ogawa S
Nature; 2009 Jun; 459(7247):712-6. PubMed ID: 19412163
[TBL] [Abstract][Full Text] [Related]
20. A20 Restricts Inflammatory Response and Desensitizes Gingival Keratinocytes to Apoptosis.
Li Y; Mooney EC; Xia XJ; Gupta N; Sahingur SE
Front Immunol; 2020; 11():365. PubMed ID: 32218782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
